Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
90.3M
-
Shares change
-
+8.51M
-
Total reported value, excl. options
-
$99.3M
-
Value change
-
+$9.37M
-
Number of buys
-
23
-
Number of sells
-
-6
-
Price
-
$1.10
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q3 2023
30 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q3 2023.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.3M shares
of 139M outstanding shares and own 64.81% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (73.1M shares), Altium Capital Management LP (8.93M shares), Nantahala Capital Management, LLC (4M shares), VANGUARD GROUP INC (1.49M shares), RENAISSANCE TECHNOLOGIES LLC (670K shares), AMH Equity Ltd (594K shares), AWM Investment Company, Inc. (469K shares), GEODE CAPITAL MANAGEMENT, LLC (261K shares), Crescent Grove Advisors, LLC (212K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (169K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.